Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuulia Vallius

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Scientific Reports|July 23, 2020
Author Correction: Virtual clinical trials identify effective combination therapies in ovarian cancerEmilia Kozłowska, Tuulia Vallius, Johanna Hynninen, et al.
Scientific Reports|December 12, 2019
Virtual clinical trials identify effective combination therapies in ovarian cancerEmilia Kozłowska, Tuulia Vallius, Johanna Hynninen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 21, 2017
Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancerTuulia Vallius, Johanna Hynninen, Annika Auranen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 6, 2014
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancerTuulia Vallius, Johanna Hynninen, Annika Auranen, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
STITCH links cellular morphology and gene expression in spatial transcriptomicsShashwat Kumar, Yingxiao Shi, Tuulia Vallius, et al.
Cancer Research|May 18, 2018
Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian CancerEmilia Kozłowska, Anniina Färkkilä, Tuulia Vallius, et al.
Gynecologic Oncology|October 31, 2015
18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancerTuulia Vallius, Anniina Peter, Annika Auranen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2018
<sup>18</sup>F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancerTuulia Vallius, Johanna Hynninen, Jukka Kemppainen, et al.
Elife|June 30, 2026
Restraint of melanoma progression by cells in the local skin environmentYilun Ma, Mohita Tagore, Miranda V Hunter, et al.
Communications Biology|November 18, 2022
UnMICST: Deep learning with real augmentation for robust segmentation of highly multiplexed images of human tissuesClarence Yapp, Edward Novikov, Won-Dong Jang, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Scientific Reports|July 23, 2020
Author Correction: Virtual clinical trials identify effective combination therapies in ovarian cancerEmilia Kozłowska, Tuulia Vallius, Johanna Hynninen, et al.
Scientific Reports|December 12, 2019
Virtual clinical trials identify effective combination therapies in ovarian cancerEmilia Kozłowska, Tuulia Vallius, Johanna Hynninen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 21, 2017
Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancerTuulia Vallius, Johanna Hynninen, Annika Auranen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 6, 2014
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancerTuulia Vallius, Johanna Hynninen, Annika Auranen, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
STITCH links cellular morphology and gene expression in spatial transcriptomicsShashwat Kumar, Yingxiao Shi, Tuulia Vallius, et al.
Cancer Research|May 18, 2018
Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian CancerEmilia Kozłowska, Anniina Färkkilä, Tuulia Vallius, et al.
Gynecologic Oncology|October 31, 2015
18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancerTuulia Vallius, Anniina Peter, Annika Auranen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2018
<sup>18</sup>F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancerTuulia Vallius, Johanna Hynninen, Jukka Kemppainen, et al.
Elife|June 30, 2026
Restraint of melanoma progression by cells in the local skin environmentYilun Ma, Mohita Tagore, Miranda V Hunter, et al.
Communications Biology|November 18, 2022
UnMICST: Deep learning with real augmentation for robust segmentation of highly multiplexed images of human tissuesClarence Yapp, Edward Novikov, Won-Dong Jang, et al.
Pageof 3